• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

40例急性心肌梗死溶栓治疗的初步报告

[A primary report on thrombolytic therapy of acute myocardial infarction in 40 cases].

作者信息

Hu D

机构信息

First Hospital, Beijing Medical University.

出版信息

Zhonghua Xin Xue Guan Bing Za Zhi. 1991 Jun;19(3):143-4, 196.

PMID:1914852
Abstract

Forty cases with acute myocardial infarction were treated by thrombolysis from June, 1989 through September, 1990. 32 males and 8 females. Age 44-76 (60 +/- 7.1) years. Coronary angiography was performed in 19 patients 10 days after intravenous thrombolysis on average. With intravenous thrombolysis the reperfusion rates were 69.2% (9/13) for streptokinase and 53.8% (7/13) for urokinase (Green Cross Company, Japan) according to the clinical criteria. No reperfusion was observed in 8 cases treated by China-made urokinase. The reperfusion rate of intracoronary thrombolysis was 85.7% (6/7). 5 cases had hemorrhagic complications, skin ecchymosis in 2 and mild gastrointestinal bleeding in 3, and no transfusion was necessary. No intracranial hemorrhage was noticed.

摘要

1989年6月至1990年9月,对40例急性心肌梗死患者进行了溶栓治疗。其中男性32例,女性8例。年龄44 - 76岁(平均60±7.1岁)。平均在静脉溶栓治疗10天后,对19例患者进行了冠状动脉造影。根据临床标准,静脉溶栓治疗中,链激酶的再灌注率为69.2%(9/13),尿激酶(日本绿十字公司生产)的再灌注率为53.8%(7/13)。国产尿激酶治疗的8例患者未观察到再灌注。冠状动脉内溶栓的再灌注率为85.7%(6/7)。5例出现出血并发症,2例皮肤瘀斑,3例轻度胃肠道出血,均无需输血。未发现颅内出血。

相似文献

1
[A primary report on thrombolytic therapy of acute myocardial infarction in 40 cases].40例急性心肌梗死溶栓治疗的初步报告
Zhonghua Xin Xue Guan Bing Za Zhi. 1991 Jun;19(3):143-4, 196.
2
Effects of thrombolytic therapy on recanalization in different starting time of treatment after acute myocardial infarction.溶栓治疗对急性心肌梗死后不同治疗起始时间再通的影响。
Chin Med J (Engl). 1997 Jan;110(1):53-5.
3
Prevalence of late potentials after myocardial infarction treated with systemic thrombolysis or primary percutaneous transluminal coronary angioplasty.接受全身溶栓治疗或直接经皮冠状动脉腔内血管成形术的心肌梗死后晚期电位的患病率。
G Ital Cardiol. 1998 Jan;28(1):3-11.
4
Percutaneous transluminal coronary angioplasty for acute myocardial infarction.经皮腔内冠状动脉成形术治疗急性心肌梗死
Cardiol Clin. 1989 Nov;7(4):837-51.
5
[Current status and prospect of reperfusion therapy and PTCA in acute myocardial infarction in China].[中国急性心肌梗死再灌注治疗及经皮冠状动脉腔内血管成形术的现状与展望]
Zhonghua Xin Xue Guan Bing Za Zhi. 1991 Jun;19(3):131.
6
[Evaluation of clinical criteria of coronary artery recanalization in acute myocardial infarction].[急性心肌梗死冠状动脉再通临床标准的评估]
Zhonghua Xin Xue Guan Bing Za Zhi. 1991 Jun;19(3):139-42, 196.
7
[Mechanical reperfusion in acute myocardial infarction after failure of thrombolysis with intravenous streptokinase].
Rev Med Chil. 1993 Oct;121(10):1161-73.
8
Thrombolysis in acute myocardial infarction.急性心肌梗死的溶栓治疗
Br J Hosp Med. 1992;47(8):572-6, 578-80.
9
Intra-coronary thrombolysis with streptokinase or lys-plasminogen/urokinase in acute myocardial infarction: effects on recanalization and blood fibrinolysis.
Thromb Haemost. 1983 Dec 30;50(4):792-6.
10
[Intravenous thrombolysis with domestic urokinase in 40 cases of acute myocardial infarction].国产尿激酶静脉溶栓治疗40例急性心肌梗死
Zhonghua Nei Ke Za Zhi. 1993 Oct;32(10):679-81.